Title:
COMPOSITION FOR PREVENTING OR TREATING BENIGN PROSTATIC HYPERPLASIA, CONTAINING MORUS ALBA LINNE EXTRACT
Document Type and Number:
WIPO Patent Application WO/2017/146486
Kind Code:
A1
Abstract:
The present invention relates to a composition for preventing or treating benign prostatic hyperplasia, containing a Morus alba Linne extract and a Curcumae Rhizoma extract and, specifically, to: a pharmaceutical composition, a food composition and a quasi-drug composition for preventing or treating benign prostatic hyperplasia, all of which contain a Morus alba Linne extract or a fraction thereof and a Curcumae Rhizoma extract or a fraction thereof as active ingredients; and a method for preventing or treating benign prostatic hyperplasia by using the pharmaceutical composition. The composition containing, as an active ingredient, a Morus alba Linne extract, a Curcumae Rhizoma extract or a mixture of a Morus alba Linne extract and a Curcumae Rhizoma extract, of the present invention, has a similar or superior effect of enabling benign prostatic hyperplasia to be prevented, alleviated and treated, in comparison to when performing treatment with finasteride, which is used as a drug for benign prostatic hyperplasia. In addition, the composition of the present invention is derived from a natural product, thereby being safely usable for preventing, treating and alleviating benign prostatic hyperplasia without side effects.
Inventors:
SHIN HYEUN KYOO (KR)
LEE MEE YOUNG (KR)
SEO CHANG SEOB (KR)
JEON WOOYOUNG (KR)
HA HYEKYUNG (KR)
LEE MEE YOUNG (KR)
SEO CHANG SEOB (KR)
JEON WOOYOUNG (KR)
HA HYEKYUNG (KR)
Application Number:
PCT/KR2017/002001
Publication Date:
August 31, 2017
Filing Date:
February 23, 2017
Export Citation:
Assignee:
KOREA INST ORIENTAL MEDICINE (KR)
International Classes:
A61K36/605; A23L33/105; A61K36/906
Foreign References:
| KR101515533B1 | 2015-04-29 | |||
| CN1259905C | 2006-06-21 |
Other References:
KOLLAR, P. ET AL.: "Prenylated Flavonoids from Morus Alba L. Cause Inhibition of Gl/S Transition in THP-1 Human Leukemia Cells and Prevent the Lipopolysaccharide-induced Inflammatory Response", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2013, no. 350519, 2013, pages 1 - 13, XP055413294
DEVI, B. ET AL.: "Morus Alba Linn: a Phytopharmacological Review", INTERNATIONAL JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, vol. 5, no. 2, 2013, pages 14 - 18, XP055134293
KIM, S. K. ET AL.: "Inhibitory Effect of Curcumin on Testosterone Induced Benign Prostatic Hyperplasia Rat Model", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 15, no. 380, 2015, pages 1 - 7, XP055328092
DEVI, B. ET AL.: "Morus Alba Linn: a Phytopharmacological Review", INTERNATIONAL JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, vol. 5, no. 2, 2013, pages 14 - 18, XP055134293
KIM, S. K. ET AL.: "Inhibitory Effect of Curcumin on Testosterone Induced Benign Prostatic Hyperplasia Rat Model", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 15, no. 380, 2015, pages 1 - 7, XP055328092
Attorney, Agent or Firm:
SON, Min (KR)
Download PDF: